Accession PRJCA011591
Title Validation of a highly sensitive Sanger sequencing in detecting EGFR mutations from circulating tumor DNA in patients with lung cancers
Relevance Medical
Data types clinical data
Organisms Homo sapiens
Description This study aimed to evaluate the performance of the BDA Sanger method for the EGFR mutation detection in the ctDNA from lung cancer patients. A total of 195 plasma samples of lung cancer patients were included.
Sample scope clinical data
Release date 2022-09-01
Grants
Agency program Grant ID Grant title
National Natural Science Foundation of China (NSFC) 81972000
National Natural Science Foundation of China (NSFC) 82172348
National Natural Science Foundation of China (NSFC) 81902139
Science and Technology Commission of Shanghai 21YF1440200
Zhongshan Hospital 2018ZSLC05
Zhongshan Hospital 2020ZSLC54
Zhongshan Hospital 2021ZSQN37
Zhongshan Hospital 2021ZSQN38
the Constructing Project of Clinical Key Disciplines in Shanghai shslczdzk03302
the Key Medical and Health Projects of Xiamen YDZX20193502000002
Submitter Huiqin Jiang (jiang.huiqin@zs-hospital.sh.cn)
Organization Zhongshan Hospital, Fudan University
Submission date 2022-09-01

Project Data

Resource name Description